References
- Schwartz RH. Urine testing in the detection of drugs of abuse. Arch Intern Med 1988;148:2407–12.
- Reisfield GM, Goldberger BA, Bertholf RL.‘False-positive’ and ‘false negative’ test results in clinical urine drug testing. Bioanalysis 2009;1:937–52.
- Peat MA. Analytical and technical aspects of testing for drug abuse: confirmatory procedures. Clin Chem 1988;34: 471–3.
- Goldberger BA, Cone EJ. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry. J Chromatogr A 1994;15:73–86.
- Attema-de Jonge ME, Peeters SY, Franssen EJ. Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department. J Emerg Med 2011;42:682–91.
- Bagoien G, Morken G, Zahlsen K, Aamo T, Spigset O. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit. J Clin Psychopharmacol 2009;29:248–54.
- Basilicata P, Pieri M, Settembre V, Galdiero A, Della Casa E, Acampora A, Miraglia N. Screening of several drugs of abuse in Italian workplace drug testing: performance comparisons of on-site screening tests and a fluorescence polarization immunoassay-based device. Anal Chem 2011;83:8566–74.
- Beck O, Kraft M, Moeller MR, Smith BL, Schneider S, Wennig R. Frontline immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens. Ann Clin Biochem 2000;37: 199–204.
- Crouch DJ, Frank JF, Farrell LJ, Karsch HM, Klaunig JE. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices. J Anal Toxicol 1998;22: 493–502.
- Crouch DJ, Hersch RK, Cook RF, Frank JF, Walsh JM. A field evaluation of five on-site drug-testing devices. J Anal Toxicol 2002;26:493–9.
- Haller CA, Stone J, Burke V, Branch J, Chen K, Gross S. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory. J Anal Toxicol 2006;30:106–11.
- Mordal J, Holm B, Mörland J, Bramness JG. Recent substance intake among patients admitted to acute psychiatric wards physician's assessment and on-site urine testing compared with comprehensive laboratory analyses. J Clin Psychopharmacol 2010;30:455–9.
- Tijdink JK, van den Heuvel J, Vasbinder EC, van de Ven PM, Honig A. Does on-site urine toxicology screening have an added diagnostic value in psychiatric referrals in an emergency setting?Gen Hosp Psychiatry 2011;33:626–30.
- von Mach MA, Weber C, Meyer MR, Weilemann LS, Maurer HH, Peters FT. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Ther Drug Monit 2007;29:27–39.
- Peace MR, Tarnai LD, Poklis A. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine. J Anal Toxicol 2000;24:589–94.
- Yang JM, Lewandrowski KB. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT). Clin Chim Acta 2001;307:27–32.
- Taylor EH, Oertli EH, Wolfgang JW. Accuracy of five onsite immunoassay drugs of-abuse testing devices. J Anal Toxicol 1999;23:119–24.
- Maralikova B, Weinmann W. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J Chromatogr B 2004;811:21–30.